Navigation Links
Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
Date:6/29/2011

PARIS, June 29, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it entered into a research collaboration with Weill Cornell Medical College to develop new anti-infectives that aim to shorten the course of treatment of tuberculosis (TB) and provide effective therapies against drug-susceptible and drug-resistant strains of TB.

(Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)

Under the terms of the collaboration, Sanofi will provide 80,000 chemical compounds to Dr. Carl Nathan's laboratory at Weill Cornell, where the compounds will be screened to assess their ability to inhibit growth of Mycobacterium tuberculosis. Weill Cornell has secured funding for the screening activities conducted by Dr. Nathan's team from the Bill & Melinda Gates Foundation. Sanofi and Weill Cornell will jointly determine if any compounds screened through the collaboration should be brought forward for optimization and further development.

"Since discovering rifampicin in the early 1960s, Sanofi has continued to pursue new therapeutic approaches to combat TB, including new vaccines and drug candidates with new mechanisms of action," said Elias Zerhouni, President, Global R&D at Sanofi. "This research collaboration with Weill Cornell will enable us to explore the potential of our existing compound library and pool the extensive knowledge of Dr. Nathan and his colleagues with Sanofi's drug development expertise to benefit TB patients worldwide in continuation of our long standing commitment to global health."

Every year, more than 1.7 million people worldwide die from TB. Today's TB drugs are more than 40 years old and must be taken for six to nine months for drug-sensitive disease and up to 24 months for drug-resistant disease. Long, demanding treatment schedules prove too much for many patients and the resulting
'/>"/>

SOURCE Sanofi
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sanofi Pasteur Commends Winners of International BioGENEius Challenge
2. Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen
3. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
4. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
5. Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims
6. sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
7. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
8. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
9. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
10. Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
11. Navinta LLC is Pleased to Announce US FDA Approval of Sodium Ferric Gluconate Injection in Sucrose [a generic equivalent of Ferrlecit® Injection by Sanofi Aventis] Based on Its Proprietary Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... -- Inventor of ProTide technology ...   NuCana, a clinical stage biopharmaceutical company ... portfolio of novel anti-cancer medicines, today announced the appointment ... Officer. Professor McGuigan was the original inventor ... Medicinal Chemistry at the Cardiff School of Pharmacy and ...
(Date:6/30/2015)... BRUSSELS , July 1, 2015 ... proud to announce the winners of the first Ansell ... European Operating Room (O.R.) Nurses. The 2015 award, organised ... (EORNA), recognizes perioperative nurses who display exceptional skill and ... to staff education and development. Award ceremonies are taking ...
(Date:6/30/2015)... , June 30, 2015  The MEDevice San ... year, is an event dedicated to bringing medtech professionals ... issues and topics affecting the industry today. This year,s ... the challenges and opportunities facing today,s medtech professional in ... and to register for MEDevice San Diego, please visit: ...
Breaking Medicine Technology:Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2
(Date:6/30/2015)... ... 30, 2015 , ... The board certified otolaryngologists at Clear ... to inform potential sinus surgery patients about ear, nose, and throat (ENT) ailments ... a wide variety of ENT issues including hearing loss, ear infections, dizziness, sleep ...
(Date:6/30/2015)... ... June 30, 2015 , ... Villa Health Care ... centers in the country. To spread the word, Villa Health Care Center created ... is, indeed, worthy of five stars. While Medicare centers its rating on health ...
(Date:6/30/2015)... ... 2015 , ... The LIV Fertility Center in Puerto Vallarta is ... age to pursue egg freezing. Statistics show that 20 percent of women are waiting ... percent increase since the 1970s. , Sadly, for women who have delayed parenthood for ...
(Date:6/30/2015)... , ... June 30, 2015 , ... According to a ... 2007 to 2013 while heroin-related deaths more than tripled in the same period—leading a ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, asserts that ...
(Date:6/30/2015)... Los Angeles, CA (PRWEB) , ... June 30, 2015 , ... ... Reasons You Have Acne ,” listed five triggers that most people would not ... cloths, hair care products, and toothpaste. The primary causes of acne are ...
Breaking Medicine News(10 mins):Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:Villa Health Care Center Announces Highest Care Rating in New Video 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2
... A recently published study revealed that virological breakthrough (VBT) ... chronic hepatitis B. Nearly 40% of the VBTs found ... this retrospective study are published in the May issue ... on behalf of the American Association for the Study ...
... drug memantine submitted a supplementary analysis of study data, the ... sees proof of a benefit of the drug for cognitive ... of daily living, at least for a treatment period of ... benefit assessment of 2009. IQWiG had repeatedly called upon the ...
... Goodwin HealthDay Reporter , TUESDAY, April 26 (HealthDay ... attacks, such as clot-busting drugs and rapid angioplasty, has led ... Researchers used data from a Swedish coronary care registry ... type of deadly heart attack known as STEMI between 1996 ...
... for publication in The Endocrine Society,s Journal of Clinical ... white children with vitamin D deficiency both had higher fat ... of fat just under their skin and white children were ... internal organs. Studies in adults and children have shown ...
... , TUESDAY, April 26 (HealthDay News) -- Seniors who ... of developing Alzheimer,s disease, a new study suggests. ... house causes dementia, and other factors could explain the ... cost of isolation, said lead investigator Bryan D. James, ...
... University bioengineering students in collaboration with the Texas Heart ... to arrhythmia victims headed toward cardiac arrest. For ... created a unique pad system for automated external defibrillators ... back into a proper rhythm in an emergency. ...
Cached Medicine News:Health News:Hepatitis B virus reemerges with long-term nucleoside analog treatment 2Health News:Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine 2Health News:Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine 3Health News:Evidence-Based Heart Attack Care Reduces Deaths: Study 2Health News:Evidence-Based Heart Attack Care Reduces Deaths: Study 3Health News:Vitamin D deficiency is associated with different types of obesity in black and white children 2Health News:Being 'Housebound' Linked to Alzheimer's in Elderly 2Health News:Being 'Housebound' Linked to Alzheimer's in Elderly 3Health News:Unique AED pads give hearts a second chance 2
For the quantitative determination of uric acid in serum....
For determination of uric acid in serum, plasma or urine. For Hitachi 704 / 911. Available with Calibrator: Trucal U and controls: Trulab N and Trulab P....
For the quantitative determination of uric acid in serum....
For the quantitative determination of Uric Acid in serum. Linearity: 25 mg/dl....
Medicine Products: